Jaktinib hydrochloride tablets    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
271Ankylosing spondylitis1

271. Ankylosing spondylitis    [ 531 clinical trials,   343 drugs,   (DrugBank: 66 drugs),   41 drug target genes,   141 drug target pathways]
Searched query = "Ankylosing spondylitis", "Spondylarthritis ankylopoietica"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 531 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04507659
(ClinicalTrials.gov)
December 20204/8/2020Jaktinib Hydrochloride Tablets In The Treatment of Active Ankylosing SpondylitisA Multi-center, Randomized, Double-blind, Placebo, Parallel-controlled Phase ? Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Patients With Active Ankylosing SpondylitisAnkylosing SpondylitisDrug: Jaktinib Hydrochloride Tablets;Drug: PlaceboSuzhou Zelgen Biopharmaceuticals Co.,LtdNULLNot yet recruiting18 Years65 YearsAll105Phase 2NULL